Valuation: IRADIMED CORPORATION

Market Cap 1.21B 1.06B 981M 917M 1.72B 114B 1.75B 11.77B 4.55B 56.31B 4.54B 4.44B 196B P/E 2026 *
49.6x
P/E 2027 * 43.7x
Enterprise Value 1.21B 1.06B 981M 917M 1.72B 114B 1.75B 11.77B 4.55B 56.31B 4.54B 4.44B 196B EV / Sales 2026 *
13.3x
EV / Sales 2027 * 12x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-0.83%
1 week+3.05%
Current month+3.54%
1 month+1.92%
3 months-7.03%
6 months-3.29%
Current year-3.51%
1 week 90.18
Extreme 90.18
96
1 month 87.91
Extreme 87.91
98.41
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
06-20Fiscal year

Chief Financial Officer

13,911 0.1088%
06-04Sell

Director

-3,000 0.0235%
06-01Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%+3.05%+55.21%+98.12% 1.21B
-0.81%-7.79%-20.38%-24.12% 12.33B
+3.11%-6.38%+80.61%+17.33% 4.77B
-1.58%-2.75%-37.47%-65.40% 1.2B
-3.57%-6.65%-39.09%-47.37% 1.13B
-2.78%-4.97%-42.57% - 928M
-2.02%-15.87%+157.86%+168.59% 634M
-1.41%+7.54% - - 354M
+2.86%+6.12%-56.63%+209.17% 248M
+15.75%+21.58%+133.68%-23.87% 145M
Average -0.59%-1.24%+25.69%+41.56% 2.29B
Weighted average by Cap. -0.24%-2.87%+7.83%-3.35%

Financials

2026 *2027 *
Net sales 91.2M 80.24M 73.9M 69.15M 129M 8.61B 132M 887M 343M 4.24B 342M 335M 14.75B 101M 88.77M 81.76M 76.5M 143M 9.52B 146M 982M 380M 4.7B 379M 371M 16.32B
Net income 24.55M 21.6M 19.89M 18.61M 34.85M 2.32B 35.54M 239M 92.39M 1.14B 92.18M 90.16M 3.97B 27.8M 24.46M 22.53M 21.08M 39.47M 2.62B 40.25M 270M 105M 1.29B 104M 102M 4.5B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
25/06/26 $93.87 -0.83% 98,588
24/06/26 $94.66 +2.49% 109,511
23/06/26 $92.36 +0.73% 148,140
22/06/26 $91.69 -0.55% 95,062
18/06/26 $92.20 +1.22% 182,287
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
93.87USD
Average target price
118.00USD
Spread / Average Target
+25.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock